(Q37104719)

18 August 2017

title

A descriptive evaluation of unfractionated heparin use during pregnancy (English)

1 reference

18 August 2017

0 references

1 reference

Nathan P Clark

1

1 reference

18 August 2017

Thomas Delate

2

1 reference

18 August 2017

Daniel M Witt

3

1 reference

18 August 2017

Suzanne Parker

4

1 reference

18 August 2017

Robert McDuffie

5

1 reference

18 August 2017

publication date

8 March 2008

1 reference

Journal of Thrombosis and Thrombolysis

18 August 2017

published in

1 reference

18 August 2017

volume

27

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

267-273

1 reference

Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias

18 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11239-008-0207-0

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11239-008-0207-0

Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk.

21 January 2018

1 reference

12 December 2020

No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin: a metaanalysis

1 reference

12 December 2020

Thromboprophylaxis with unmonitored intermediate-dose low molecular weight heparin in pregnancies with a previous arterial or venous thrombotic event

1 reference

12 December 2020

Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry

1 reference

12 December 2020

Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man

1 reference

12 December 2020

Bone mineral density during long-term prophylaxis with heparin in pregnancy

1 reference

12 December 2020

Long-term outcome of deep venous thrombosis during pregnancy treated with unfractionated heparin or low molecular weight heparin

1 reference

12 December 2020

Bone density changes in pregnant women treated with heparin: a prospective, longitudinal study

1 reference

12 December 2020

Thrombophilia and pregnancy complications

1 reference

12 December 2020

Risks to the fetus of anticoagulant therapy during pregnancy

1 reference

12 December 2020

Thrombophilic disorders and fetal loss: a meta-analysis

1 reference

12 December 2020

Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.

1 reference

12 December 2020

Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies

1 reference

12 December 2020

Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin

1 reference

12 December 2020

Bone density changes in women who receive thromboprophylaxis in pregnancy

1 reference

12 December 2020

The effects of long-term heparin therapy during pregnancy on bone density. A prospective matched cohort study

1 reference

12 December 2020

Inherited thrombophilias in pregnant patients: detection and treatment paradigm

1 reference

12 December 2020

Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women

1 reference

12 December 2020

More on: is laboratory monitoring of low-molecular-weight heparin necessary?

1 reference

12 December 2020

Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism

1 reference

12 December 2020

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy

1 reference

12 December 2020

Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment

1 reference

12 December 2020

Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin.

1 reference

12 December 2020

Inherited thrombophilia: treatment during pregnancy

1 reference

12 December 2020

A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation

1 reference

12 December 2020

Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin

1 reference

12 December 2020

Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group

1 reference

12 December 2020

Incomplete Reversal of Enoxaparin-Induced Bleeding by Protamine Sulfate

1 reference

12 December 2020

Anti Xa monitoring during treatment with low molecular weight heparin or danaparoid: inter-assay variability.

1 reference

12 December 2020

Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder

1 reference

12 December 2020

Anticoagulation in pregnancy: a survey of current practice

1 reference

12 December 2020

Effects of fondaparinux compared with dalteparin, enoxaparin and unfractionated heparin on human osteoblasts

1 reference

12 December 2020

Maternal and fetal sequelae of anticoagulation during pregnancy

1 reference

12 December 2020

Coumarins during pregnancy: long-term effects on growth and development of school-age children.

1 reference

12 December 2020

Preventing adverse obstetric outcomes in women with genetic thrombophilia

1 reference

12 December 2020

A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry

1 reference

12 December 2020

10.1007/S11239-008-0207-0

Identifiers

DOI

1 reference

18 August 2017

1 reference